Detalhe da pesquisa
1.
Movement in Aesthetic Experiences: What We Can Learn from Parkinson Disease.
J Cogn Neurosci
; 33(7): 1329-1342, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496397
2.
Differences in the Presentation and Progression of Parkinson's Disease by Sex.
Mov Disord
; 36(1): 106-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002231
3.
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
Ann Neurol
; 85(6): 801-811, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30973966
4.
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?
Mov Disord
; 35(9): 1618-1625, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32520435
5.
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
PLoS Med
; 16(10): e1002931, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31603904
6.
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
Mov Disord
; 34(12): 1839-1850, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31505070
7.
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
Mov Disord
; 33(2): 289-297, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168904
8.
Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease.
J Neurol Neurosurg Psychiatry
; 87(12): 1303-1310, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27071646
9.
Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.
Mov Disord
; 31(1): 126-34, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26249849
10.
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.
Mov Disord
; 30(6): 805-12, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25227208
11.
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.
Mov Disord
; 29(14): 1809-15, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381961
12.
Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level.
NPJ Parkinsons Dis
; 10(1): 97, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702337
13.
Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
J Parkinsons Dis
; 11(2): 737-745, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386814
14.
Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study.
J Parkinsons Dis
; 11(2): 757-765, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492247
15.
Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease.
Int J Geriatr Psychiatry
; 24(5): 443-51, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19016252
16.
From action to abstraction: The sensorimotor grounding of metaphor in Parkinson's disease.
Cortex
; 121: 362-384, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678683
17.
Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.
Mov Disord Clin Pract
; 6(6): 440-445, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31392244
18.
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.
Neurol Genet
; 5(4): e348, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31404238
19.
Decision-making capacity and competency in the elderly: a clinical and neuropsychological perspective.
NeuroRehabilitation
; 23(5): 403-13, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957727
20.
Statins and Cognition in Parkinson's Disease.
J Parkinsons Dis
; 7(4): 661-667, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28922167